Table 6.
Bunker [39] | Kilian et al. [33] | Lho et al. [19] | Uhthoff and Boileau [41] | Xu et al. [37] | ||
---|---|---|---|---|---|---|
Techniques used | IHC | X | X | X | X | |
ICC | X | |||||
RTPCR | X | X | ||||
ELISA | X | |||||
Matrix components | Fibroblasts | ↑ | ↓ | ↑ | ||
Myofibroblasts | ↑ | ↓ | ||||
Cytokines | IL- 1α | ↑ | ||||
IL-1β | ↑ | |||||
IL-6 | ↑ | |||||
TNF-α | ↑ | |||||
Immune factors | Leukocytes | ↓ | ||||
Macrophages | ↓ | |||||
Neuronal factors | PGP9.5 | ↑ | ||||
GAP43 | ↑ | |||||
P75 | ↑ | |||||
Vascular factors | CD34 | ↑ | ||||
Enzymes | COX1 | ↑ | ||||
COX2 | ↑ |
↑ (increased), ↓ (decreased), IHC (immunohistochemistry analysis), ICC (immunocytochemical examination), RTPCR (real time reverse transcription-polymerase chain reaction), ELISA (enzyme-linked immunosorbent assay), IL-1α (interleukin 1 alpha), IL-1β (interleukin 1 beta), IL-6 (interleukin 6), TNF-α (tumour necrosis factor alpha), PGP9.5 (polyclonal rabbit antiprotein gene product 9.5), GAP43 (monoclonal mouse antigrowth-associated protein 43), P75 (nerve growth factor receptor p75), CD34 (monoclonal mouse antihuman CD34), COX1 (cyclooxygenase 1), COX 2 (cyclooxygenase 2)